Evidence map›Paper›PMID 28679651›Full record

ArticleHaematologica2017

Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.

Iman Meziane, Stefanie Huhn, Miguel Inacio da Silva Filho, Niels Weinhold, Chiara Campo, Jolanta Nickel, Per Hoffmann, Markus M Nöthen, Karl-Heinz Jöckel, Stefano Landi and 16 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 13 institutions in 6 countries.

Iman MezianeDivision of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stefanie HuhnDepartment of Internal Medicine V, University of Heidelberg, Germany.
Miguel Inacio da Silva FilhoDivision of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Niels WeinholdDepartment of Internal Medicine V, University of Heidelberg, Germany.
Chiara CampoDivision of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Jolanta NickelDepartment of Internal Medicine V, University of Heidelberg, Germany.
Per HoffmannInstitute of Human Genetics, University of Bonn, Germany.
Markus M NöthenInstitute of Human Genetics, University of Bonn, Germany.
Karl-Heinz JöckelInstitute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Germany.
Stefano LandiDepartment of Biology, University of Pisa, Italy.
Jonathan S MitchellDivision of Genetics and Epidemiology, The Institute of Cancer Research, Surrey, UK.
David JohnsonDivision of Molecular Pathology, The Institute of Cancer Research, Surrey, UK.
Anna JauchInstitute of Human Genetics, University of Heidelberg, Germany.
Gareth J MorganMyeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Richard HoulstonDivision of Genetics and Epidemiology, The Institute of Cancer Research, Surrey, UK.
Hartmut GoldschmidtDepartment of Internal Medicine V, University of Heidelberg, Germany.
Paolo MilaniAmyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
Giampaolo MerliniAmyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
Dorota RowcienoNational Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, UK.
Philip HawkinsNational Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, UK.
Ute HegenbartDepartment of Internal Medicine V, University of Heidelberg, Germany.
Giovanni PalladiniAmyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Pavia, Italy.
Ashutosh WechalekarNational Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, UK.
Asta FörstiDivision of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stefan O SchönlandDepartment of Internal Medicine V, University of Heidelberg, Germany.
Kari HemminkiDivision of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Heidelberg University · DEInstitute of Cancer Research · GBIstituti di Ricovero e Cura a Carattere Scientifico · ITThe Royal Free Hospital · GBGerman Cancer Research Center · DELife & Brain (Germany) · DELund University · SENational Center for Tumor Diseases · DEUniversity College London · GBUniversity of Arkansas for Medical Sciences · USUniversity of Bonn · DEUniversity of Duisburg-Essen · DEUniversity of Pisa · IT

Funding

Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genome-Wide Association StudyHumansImmunoglobulin Light-chain AmyloidosisMultiple MyelomaPolymorphism, Single Nucleotide

Identifiers

PMID28679651
PMCPMC5622874
OpenAlexW2729564033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.